As the particles are often pseudotyped with the envelope of the vesicular stomatitis virus (VSV), the vector can serve to introduce genes into a broad range of tissues and can be used in vivo.

Current lentiviral vector systems (the third generation) generate virus particles using four plasmids and a producer cell line. The rationale behind four plasmids is to enhance safety, as ...

senior vice president of process and analytical development at viral vector manufacturer iVexSol, which uses its lentiviral vector technology to reduce the time and expense involved in cell and ...

The FDA notification came seven weeks after the New England Journal of Medicine (NEJM) published a report that seven of 67 ...

The agency is also evaluating if there's a need for further regulatory action based on reports of hematologic malignancies from clinical trials of the therapy.

The popularity of viral vector-based gene therapies and vaccines is rapidly growing ... Download this application note from Thermo Fisher Scientific to learn how scientists have used their lentiviral ...

TASS/. Experts of Russia’s Federal Medical and Biological Agency (FMBA) are now developing a new medicine against Human Immunodeficiency Virus (HIV), based on lentiviral vector, the agency’s ...

To develop the next generation of in vivo T cell therapy, Novartis will leverage Vyriad's active targeting lentiviral vector ...

This study presents important findings on cold tolerance shared between hibernating and non-hibernating mammals, identifying a key molecule, GPX4, through multi-species genome-wide CRISPR screens. The ...

Oxford, UK – 20 November 2024: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces it will host a free 60-minute webinar exploring how advanced robotics can be ...